Introduction
The Pitt — Episode 3, final confirmation scene:
"There is a test called a cerebral perfusion study." — Dr. Robby
"Then let's do it." — Nick's family member
"But you have to understand — that will be the last test we would do. If it comes back showing no blood flow to Nick's brain, it would confirm beyond a shadow of a doubt that there's been brain death." — Dr. Robby
This scene captures with precision the weight carried by cerebral perfusion scintigraphy: it is no longer one test among many — it is the definitive one. Nick's family asked for one more chance at certainty, and Dr. Robby was honest: this would be the final step, and its result would be beyond appeal.
Cerebral perfusion scintigraphy — also called cerebral scintigraphy or cerebral SPECT — is one of the most widely used confirmatory tests in brain death diagnosis. Understanding how it works, what it detects, and why its result is so definitive is essential for physicians, patients, and families facing this process.
What is Cerebral Perfusion Scintigraphy?
Cerebral perfusion scintigraphy is a nuclear medicine exam that assesses blood flow to the cerebral parenchyma in real time. It uses a radiopharmaceutical — a radioactively labeled substance that distributes through the body according to blood flow — injected intravenously and taken up by living brain cells in direct proportion to the flow they receive.
The principle is direct: living cells metabolize and take up the radiopharmaceutical; dead cells or those without flow take up nothing. An external scintillation camera detects the emitted radiation and generates images showing exactly which brain areas are receiving blood and which are unperfused.
The most commonly used radiopharmaceuticals include:
- 99mTc-HMPAO (Ceretec): the most used for brain death diagnosis. It crosses the blood-brain barrier and is retained in brain cells proportionally to flow.
- 99mTc-ECD (Neurolite): alternative with similar pharmacokinetic profile.
In brain death, the cessation of cerebral blood flow results in the complete absence of radiopharmaceutical uptake by the brain — the so-called hollow skull sign — while extracranial structures such as the scalp and calvaria continue to take up normally, creating a characteristic and unequivocal image.
Causes and Clinical Context
Cerebral perfusion scintigraphy is indicated as a confirmatory test for brain death in specific situations:
- Complementing the standard protocol: in the U.S. and Brazil, at least one confirmatory test beyond clinical criteria and the apnea test is required or recommended in many institutional protocols.
- Inability to perform the apnea test: severe hemodynamic instability, refractory hypoxia, or severe lung injury may contraindicate ventilator disconnection.
- Diagnostic uncertainty in brainstem reflexes: conditions such as locked-in syndrome, residual intoxications, or metabolic alterations may interfere with clinical assessment.
- Additional confirmation requested by the family: as in Nick's case, scintigraphy can be performed when the family requests more evidence before accepting the diagnosis.
Brain death from cerebral anoxia — as in Nick's case, secondary to cardiac arrest from fentanyl overdose — is one of the most frequent indications, as prolonged hypoxia causes diffuse and irreversible destruction of the cerebral parenchyma with complete collapse of the microcirculation.
Signs and Symptoms
Cerebral perfusion scintigraphy is not indicated based on patient signs and symptoms — it is part of an already well-established diagnostic protocol. The patient who arrives for the exam has already been clinically assessed and presents:
- Deep coma without response to stimuli — Glasgow 3
- Absence of all brainstem reflexes confirmed by two physicians
- Positive apnea test result — no spontaneous breathing with PaCO2 above 60 mmHg
- Complete dependence on mechanical ventilation
- Known, documented, and irreversible cause for coma
The exam sequence in the episode was exactly this: first the apnea test with CO2 at 82 mmHg, then the family's request for scintigraphy as additional confirmation — rigorously following the protocol hierarchy.
Diagnosis
Cerebral perfusion scintigraphy is part of the complementary diagnostic arsenal for brain death, alongside other accepted tests:
Electroencephalography (EEG): detects absence of cortical electrical activity. Limited by sedative drug interference and by not directly evaluating the brainstem.
Transcranial Doppler: assesses flow in the basal cerebral arteries in real time, identifying absent or retrograde flow patterns consistent with brain death. Fast and non-invasive, but operator-dependent.
Conventional cerebral angiography: historical gold standard for demonstrating absent intracranial flow. Invasive and rarely used today.
CT angiography: contrast-enhanced CT assessing arterial and venous cerebral filling. Growing acceptance in international protocols.
99mTc-HMPAO scintigraphy has the advantage of being highly specific, unaffected by sedative drugs, and providing permanent imaging documentation — making it the preferred choice in many centers and the primary alternative when EEG is inconclusive.
The Procedure Step by Step
Cerebral perfusion scintigraphy for brain death diagnosis follows this protocol:
- Confirm indication and document in the medical record all clinical criteria already met.
- Contact the nuclear medicine team for urgent radiopharmaceutical availability — 99mTc-HMPAO has a 6-hour half-life and must be prepared close to the exam time.
- Transport the patient to the nuclear medicine department with continuous monitoring and portable mechanical ventilation.
- Administer the radiopharmaceutical intravenously — standard dose of 740 to 1,110 MBq (20 to 30 mCi) of 99mTc-HMPAO.
- Wait 30 to 60 minutes for radiopharmaceutical distribution throughout the body.
- Position the patient under the scintillation camera and perform planar and tomographic (SPECT) skull image acquisition.
- The acquisition exam takes approximately 30 to 45 minutes.
- The nuclear medicine physician interprets the images and issues a report on the presence or absence of cerebral uptake.
- In brain death, the report describes the hollow skull sign: complete absence of intracranial uptake with normal uptake of the scalp and extracranial structures.
In the episode, Dr. Robby waited for the nuclear medicine result and returned to communicate it to the family — a moment depicted with great sensitivity by the series, respecting the emotional time each family needs to process this information.
Prognosis and Complications
Cerebral perfusion scintigraphy with the hollow skull sign has specificity approaching 100% for brain death diagnosis — meaning there are virtually no false positives. When the exam shows complete absence of cerebral uptake, the diagnosis is irrefutable.
Potential limitations and points of attention include:
- False negative in early brain death: rarely, in the first hours after catastrophic injury, minimal residual flow may still be present that does not represent cerebral function.
- Technical interference: errors in radiopharmaceutical preparation, inadequate dose, or equipment failure can compromise image quality.
- Radiation exposure: the patient receives a radiation dose equivalent to a brain CT scan — clinically irrelevant in the diagnostic context, but documented.
- Logistics: the need for transport to the nuclear medicine department and radiopharmaceutical preparation time may delay the process in hospitals without 24-hour service.
The exam has no direct clinical complications. The radiopharmaceutical is safe, with an extensively documented safety profile over decades of clinical use.
Frequently Asked Questions
Is cerebral perfusion scintigraphy painful?
No. The procedure is completely painless. The only physical contact with the patient is the intravenous injection of the radiopharmaceutical — a standard procedure, similar to any venous injection. The time under the scintillation camera involves no discomfort, as the equipment does not touch the patient.
What is the hollow skull sign?
The hollow skull sign is the characteristic imaging finding of brain death on cerebral scintigraphy. The images show normal radiopharmaceutical uptake in extracranial structures — scalp, facial muscles, nose — but complete absence of uptake inside the skull, where the cerebral parenchyma should appear. The result is an image in which the interior of the skull appears completely empty.
How long does the exam take to complete?
From indication to final report, the process generally takes 2 to 4 hours: 30 to 60 minutes for radiopharmaceutical preparation, 30 to 60 minutes for distribution after injection, 30 to 45 minutes for image acquisition, and variable time for the medical report. In hospitals with 24-hour nuclear medicine service, the process can be faster.
Does the family have the right to see the scintigraphy images?
Yes. The scintigraphy images are part of the patient's medical record and can be shared with the family upon request. In many cases, the responsible physician shows the images to the family during the diagnosis communication — a practice that can help with the acceptance process by making visible and concrete what the clinical data had already demonstrated.
Conclusion
Cerebral perfusion scintigraphy is the diagnostic epilogue of brain death — the exam that transforms clinical suspicion into documented imaging certainty. In Episode 3 of The Pitt, it represented the last chance Nick's family asked for to believe in a miracle — and whose result turned into a farewell.
Explore more in our Medical Procedures category. Also read about the apnea test, anoxic brain injury, the mechanical ventilator, and brain death in the ER.
Disclaimer: This content is for educational purposes only and does not substitute professional medical evaluation, diagnosis, or treatment. In case of emergency, call 911 immediately.
